Culture, arts & science

Scientist.com and PhenoVista Launch World’s First Digital Storefront Offering Research Services for the Biotech Industry

Complex phenotypic studies can be designed, purchased, and managed through the online shop SAN DIEGO–(BUSINESS WIRE)– Scientist.com, the pharma industry’s leading research marketplace, and PhenoVista,...

CORRECTING and REPLACING, Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU

The U.S. Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis and for...

European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– Over 8,000 patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia may be eligible for treatment –...

Mainstay Medical maakt bekend dat MRI-labeling op het ReActiv8® Restorative Neurostimulation-systeemTM de FDA-goedkeuring heeft ontvangen

Patiënten van de V.S. die een implantaat met ReActiv8 kregen, komen voortaan in aanmerking voor MRI-scans van het hele lichaam DUBLIN–(BUSINESS WIRE)– Mainstay Medical Holdings...

Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on ReActiv8® Restorative Neurostimulation SystemTM

U.S. patients implanted with ReActiv8 now eligible for full-body MRI scans DUBLIN–(BUSINESS WIRE)– Mainstay Medical Holdings plc today announced that the U.S. Food and Drug...

Prokarium bereikt mijlpaal met eerste patiëntdosering in klinisch PARADIGM-1-onderzoek naar niet-spierinvasieve blaaskanker

LONDEN–(BUSINESS WIRE)– Prokarium, een biofarmaceutisch bedrijf in de klinische fase dat biologische geneesmiddelen ontwikkelt via de allernieuwste synthetische biologie, kondigt vandaag de dosering aan van...

Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial

LONDON–(BUSINESS WIRE)– Prokarium, a clinical-stage biopharmaceutical company bioengineering Living Cures through cutting-edge synthetic biology, today announces the dosing of the first patient in their PARADIGM-1...

ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

BEIJING–(BUSINESS WIRE)– The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams...

Galderma Launches ‘NEXT’, a Ground-Breaking Trend Report That Unveils the Future of Aesthetics

“NEXT by Galderma” is a ground-breaking trend report based on a year of comprehensive research and collaboration with leading minds from the aesthetics community. The...

Parse Biosciences gaat met INTEGRA Biosciences samenwerken voor geautomatiseerde single-cell workflows

Automatisering zorgt voor grotere faciliteit voor single-cell projecten SEATTLE–(BUSINESS WIRE)– Parse Biosciences, een toonaangevende leverancier van toegankelijke en schaalbare single-cell sequencing-oplossingen, heeft vandaag aangekondigd dat...

Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

Automation to enable increased facility for single cell projects SEATTLE–(BUSINESS WIRE)– Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today...

Samenwerking tussen CEA en FLASH THERAPEUTICS voor de ontwikkeling van cutane celtherapie

TOULOUSE, Frankrijk & PARIJS–(BUSINESS WIRE)– Flash Therapeutics, een Franse CDMO gespecialiseerd in de bioproductie van virale vectoren voor de overdracht van genetisch materiaal, is er...

biomodal levert het 6-basen genoom met een krachtige nieuwe multi-omic-oplossing, duet evoC

Nieuwe oplossing maakt onderscheid tussen 5-methylcytosine (5mC) en 5-hydroxymethylcytosine (5hmC) en onthult ongekende inzichten in huidige en toekomstige ziektestatussen met behulp van een monster met...

biomodal Delivers the 6-Base Genome with a Powerful New Multiomic Solution, duet evoC

Novel solution distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample CAMBRIDGE, England–(BUSINESS...

Collaboration Between CEA and FLASH THERAPEUTICS for the Development of Cutaneous Cell Therapy

TOULOUSE, France & PARIS–(BUSINESS WIRE)– Flash Therapeutics, a French CDMO specialized in the bioproduction of viral vectors for the transfer of genetic material, is extremely...